Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%

Trials by Status

completed583%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
terminated

Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants

NCT04426279
completed

Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome

NCT04452266
completed

Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak

NCT04351633
completed

Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak

NCT04353011
completed

Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak

NCT04351399
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04426279

Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants

Terminated
NCT04452266

Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome

Completed
NCT04351633

Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak

Completed
NCT04353011

Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak

Completed
NCT04351399

Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak

Completed
NCT04337047

Distress in Crisis Situations During COVID-19

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6